NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Starpharma Holdings Limited (OTCQX: SPHRY)

 
SPHRY Technical Analysis
5
As on 1st Apr 2025 SPHRY STOCK Price closed @ 0.64 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.26 & Strong Sell for SHORT-TERM with Stoploss of 2.23 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

SPHRYSTOCK Price

Open 0.64 Change Price %
High 0.64 1 Day 0.05 8.47
Low 0.64 1 Week -0.03 -4.48
Close 0.64 1 Month -0.08 -11.11
Volume 224 1 Year -2.40 -78.95
52 Week High 3.04 | 52 Week Low 0.52
 
OTCQX USA Most Active Stocks
KRRGF 4.83 2.33%
FCUUF 0.52 -20.00%
ZNOG 0.14 -6.67%
ETHE 27.50 -3.34%
GBTC 64.76 -5.74%
EMHTF 0.04 33.33%
SHIEF 0.04 0.00%
GTBIF 8.95 14.74%
BABYF 0.02 -33.33%
TRSSF 2.19 -0.90%
 
OTCQX USA Top Gainers Stocks
VVCIF 0.02 100.00%
TNYBF 0.03 50.00%
ANPCY 1.26 40.00%
PAFRF 0.56 36.59%
EMHTF 0.04 33.33%
EUMNF 0.04 33.33%
LMRXF 0.50 28.21%
LMRXF 0.50 28.21%
OMZNF 0.23 27.78%
MEDIF 0.05 25.00%
 
OTCQX USA Top Losers Stocks
AIXN 0.04 -92.00%
AKOWF 0.05 -76.19%
UCASU 0.25 -63.77%
LGCP 0.03 -50.00%
BRST 0.10 -41.18%
TRCK 0.12 -36.84%
BABYF 0.02 -33.33%
AASZF 0.35 -27.08%
ISCO 0.06 -25.00%
PALAF 4.71 -24.88%
 
 
SPHRY
Daily Charts
SPHRY
Intraday Charts
Whats New @
Bazaartrend
SPHRY
Free Analysis
 
SPHRY Important Levels Intraday
RESISTANCE0.64
RESISTANCE0.64
RESISTANCE0.64
RESISTANCE0.64
RESISTANCE0.64
RESISTANCE0.64
RESISTANCE0.64
RESISTANCE0.64
 
SPHRY Forecast April 2025
4th UP Forecast2.55
3rd UP Forecast1.94
2nd UP Forecast1.56
1st UP Forecast1.18
1st DOWN Forecast0.1
2nd DOWN Forecast-0.28
3rd DOWN Forecast-0.66
4th DOWN Forecast-1.27
 
SPHRY Weekly Forecast
4th UP Forecast1.45
3rd UP Forecast1.19
2nd UP Forecast1.03
1st UP Forecast0.87
1st DOWN Forecast0.41
2nd DOWN Forecast0.25
3rd DOWN Forecast0.09
4th DOWN Forecast-0.17
 
SPHRY Forecast2025
4th UP Forecast5.23
3rd UP Forecast3.76
2nd UP Forecast2.85
1st UP Forecast1.94
1st DOWN Forecast-0.66
2nd DOWN Forecast-1.57
3rd DOWN Forecast-2.48
4th DOWN Forecast-3.95
 
 
SPHRY Other Details
Segment EQ
Market Capital 323568576.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
SPHRY Address
SPHRY
 
SPHRY Latest News
 
Your Comments and Response on Starpharma Holdings Limited
 
SPHRY Business Profile
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel, a non-antibiotic therapy for the management and prevention of bacterial vaginosis. It also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral nasal spray. In addition, the company develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase II clinical trial, and DEP irinotecan that is in phase II clinical trials for the treatment of cancer; oncology programs, such as DEP radiopharmaceuticals, DEP HER-2 ADC, and DEP gemcitabine; DEP non-oncology candidates; and DEP AZD0466, which is in Phase I/II clinical trials to treat haematological tumours. The company was founded in 1996 and is headquartered in Abbotsford, Australia. Address: 4-6 Southampton Crescent, Abbotsford, VIC, Australia, 3067
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service